{"disease":{"id":"methylmalonic-acidemia","name":"methylmalonic acidemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT00078078","title":"Clinical and Laboratory Study of Methylmalonic Acidemia","phase":"","overall_status":"RECRUITING","enrollment_count":2275,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT05910151","title":"Selective Screening of Children for Hereditary Metabolic Diseases by Tandem Mass Spectrometry in Kazakhstan","phase":"","overall_status":"UNKNOWN","enrollment_count":2250,"lead_sponsor_name":"West Kazakhstan Medical University","has_results":false},{"nct_id":"NCT03484767","title":"\"The MaP Study\": Mapping the Patient Journey in MMA and PA","phase":"","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"ModernaTX, Inc.","has_results":false},{"nct_id":"NCT04176523","title":"Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods Approach","phase":"","overall_status":"RECRUITING","enrollment_count":95,"lead_sponsor_name":"RECORDATI GROUP","has_results":false},{"nct_id":"NCT04836494","title":"A First in Human, Dose Escalation Study to Evaluate the Safety and Tolerability of BBP-671 in Healthy Volunteers and Patients With Propionic Acidemia or Methylmalonic Acidemia","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":79,"lead_sponsor_name":"CoA Therapeutics, Inc., a BridgeBio company","has_results":false},{"nct_id":"NCT04899310","title":"A Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of mRNA-3705 in Participants With Isolated Methylmalonic Acidemia","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":74,"lead_sponsor_name":"ModernaTX, Inc.","has_results":false},{"nct_id":"NCT04248062","title":"Patient and Observer Reported Outcome Measurements in Inborn Errors of Metabolism","phase":"","overall_status":"COMPLETED","enrollment_count":69,"lead_sponsor_name":"University Children's Hospital, Zurich","has_results":false},{"nct_id":"NCT06664840","title":"MyRareDiet A Novel Diet Tracking Tool","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Oregon Health and Science University","has_results":false},{"nct_id":"NCT05295433","title":"An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":56,"lead_sponsor_name":"ModernaTX, Inc.","has_results":false},{"nct_id":"NCT01599286","title":"Short-Term Outcome of N-Carbamylglutamate in the Treatment of Acute Hyperammonemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Mendel Tuchman","has_results":true},{"nct_id":"NCT04732429","title":"Study of HST5040 in Subjects With Propionic or Methylmalonic Acidemia","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":26,"lead_sponsor_name":"HemoShear Therapeutics","has_results":false},{"nct_id":"NCT05040178","title":"An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"RECORDATI GROUP","has_results":false},{"nct_id":"NCT07163364","title":"A Study to Evaluate the Effects and Safety of Hydroxocobalamin in Participants With Combined Methylmalonic Academia (cblC Type)","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.","has_results":false},{"nct_id":"NCT05438485","title":"Natural History Study of Patients With Methylmalonic Acidemia and Propionic Acidemia","phase":"","overall_status":"TERMINATED","enrollment_count":11,"lead_sponsor_name":"HemoShear Therapeutics","has_results":false},{"nct_id":"NCT05506254","title":"Long-term Follow-up Study of Patients Who Received hLB-001 Gene Therapy","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":4,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT04581785","title":"Gene Therapy With hLB-001 in Pediatric Patients With Severe Methylmalonic Acidemia","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"LogicBio Therapeutics, Inc","has_results":true},{"nct_id":"NCT04284917","title":"Long-term Efficacy of Carglumic Acid in Organic Acidemia.","phase":"NA","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT03810690","title":"Open Label Study of mRNA-3704 in Patients With Isolated Methylmalonic Acidemia","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"ModernaTX, Inc.","has_results":false}],"total":20},"guidelines":[],"source":"Drug Landscape verified database"}